PL3004061T3 - Związki 3,4-dihydroizochinolin-2(1h)-ylowe - Google Patents
Związki 3,4-dihydroizochinolin-2(1h)-yloweInfo
- Publication number
- PL3004061T3 PL3004061T3 PL14732756T PL14732756T PL3004061T3 PL 3004061 T3 PL3004061 T3 PL 3004061T3 PL 14732756 T PL14732756 T PL 14732756T PL 14732756 T PL14732756 T PL 14732756T PL 3004061 T3 PL3004061 T3 PL 3004061T3
- Authority
- PL
- Poland
- Prior art keywords
- dihydroisoquinolin
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
- C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361828740P | 2013-05-30 | 2013-05-30 | |
US201361905329P | 2013-11-18 | 2013-11-18 | |
EP14732756.3A EP3004061B8 (en) | 2013-05-30 | 2014-05-27 | 3,4-dihydroisoquinolin-2(1h)-yl compounds |
PCT/US2014/039494 WO2014193781A1 (en) | 2013-05-30 | 2014-05-27 | 3,4-dihydroisoquinolin-2(1h)-yl compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3004061T3 true PL3004061T3 (pl) | 2018-01-31 |
Family
ID=50983199
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL14732756T PL3004061T3 (pl) | 2013-05-30 | 2014-05-27 | Związki 3,4-dihydroizochinolin-2(1h)-ylowe |
Country Status (38)
Country | Link |
---|---|
US (1) | US8962654B2 (pl) |
EP (1) | EP3004061B8 (pl) |
JP (2) | JP6130590B2 (pl) |
KR (1) | KR101808933B1 (pl) |
CN (1) | CN105228985B (pl) |
AP (1) | AP2015008867A0 (pl) |
AU (2) | AU2014274435B2 (pl) |
BR (1) | BR112015029090B1 (pl) |
CA (1) | CA2912849C (pl) |
CL (1) | CL2015003444A1 (pl) |
CR (1) | CR20150622A (pl) |
CY (1) | CY1119361T1 (pl) |
DK (1) | DK3004061T3 (pl) |
DO (1) | DOP2015000289A (pl) |
EA (1) | EA029220B1 (pl) |
ES (1) | ES2647086T3 (pl) |
GT (1) | GT201500334A (pl) |
HK (1) | HK1216314A1 (pl) |
HR (1) | HRP20171696T1 (pl) |
HU (1) | HUE034607T2 (pl) |
JO (1) | JO3316B1 (pl) |
LT (1) | LT3004061T (pl) |
ME (1) | ME02838B (pl) |
MX (1) | MX2015016495A (pl) |
MY (1) | MY180751A (pl) |
NZ (1) | NZ713809A (pl) |
PE (1) | PE20152032A1 (pl) |
PH (1) | PH12015502658B1 (pl) |
PL (1) | PL3004061T3 (pl) |
PT (1) | PT3004061T (pl) |
RS (1) | RS56294B1 (pl) |
SG (1) | SG11201509310QA (pl) |
SI (1) | SI3004061T1 (pl) |
TN (1) | TN2015000514A1 (pl) |
TW (2) | TWI691489B (pl) |
UA (1) | UA118759C2 (pl) |
WO (1) | WO2014193781A1 (pl) |
ZA (1) | ZA201508213B (pl) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2010324810B2 (en) | 2009-11-27 | 2016-05-12 | Genzyme Corporation | An amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthase |
JO3316B1 (ar) * | 2013-05-30 | 2019-03-13 | Lilly Co Eli | مركبات 3، 4-داي هيدرو أيزو كوينولين -2(1h)-يل |
AR106332A1 (es) * | 2015-10-23 | 2018-01-03 | Lilly Co Eli | Forma cristalina de 2-(2,6-diclorofenil)-1-[(1s,3r)-3-(hidroximetil)-5-(3-hidroxi-3-metilbutil)-1-metil-3,4-dihidroisoquinolin-2(1h)-il]etanona |
CA3018352A1 (en) * | 2016-04-13 | 2017-10-19 | Ucb Biopharma Sprl | Tetrahydroisoquinoline derivatives |
AU2018225556A1 (en) | 2017-02-21 | 2019-10-03 | Emory University | Chemokine CXCR4 receptor modulators and uses related thereto |
EP3418270A1 (en) | 2017-06-19 | 2018-12-26 | Universidad Complutense De Madrid | Novel biphenylsulfoximines as allosteric modulators of the dopamine d1 receptor |
EP3717025B1 (en) | 2017-12-01 | 2021-11-03 | UCB Biopharma SRL | Imaging agents |
TWI725408B (zh) | 2018-04-20 | 2021-04-21 | 美商美國禮來大藥廠 | 多巴胺d1受體正向異位調節劑 |
AU2019402087B2 (en) | 2018-12-18 | 2023-04-06 | Eli Lilly And Company | Dose regimens for use of LY3154207 in the treatment of dopaminergic CNS disorders |
TWI825323B (zh) * | 2019-06-18 | 2023-12-11 | 美商美國禮來大藥廠 | 用於製備2-(2,6-二氯苯基)-1-[(1s,3r)-3-(羥甲基)-5-(3-羥基-3-甲基丁基)-1-甲基-3,4-二氫異喹啉-2(1h)-基]乙烯酮之方法及中間物 |
WO2021001286A1 (en) | 2019-07-01 | 2021-01-07 | UCB Biopharma SRL | A substituted tetrahydroisoquinoline derivative as a d1 positive allosteric modulator |
MX2021015873A (es) | 2019-07-01 | 2022-02-03 | UCB Biopharma SRL | Un derivado de tetrahidroisoquinolina sustituido como modulador alosterico positivo de d1. |
WO2022076418A1 (en) | 2020-10-07 | 2022-04-14 | Eli Lilly And Company | Phenyl-3,4-dihydroisoquinolin-2(1h)-yl-ethan-1-one derivatives as dopamine d1 receptor positive allosteric modulators |
CN116507332A (zh) | 2020-12-03 | 2023-07-28 | Ucb生物制药有限责任公司 | 八氢异喹啉基衍生物 |
MX2023007155A (es) | 2020-12-18 | 2023-06-28 | UCB Biopharma SRL | Un derivado de tetrahidroisoquinolina sustituido como un modulador alosterico positivo de d1. |
US20240083875A1 (en) * | 2020-12-18 | 2024-03-14 | UCB Biopharma SRL | Dihydroisoquinolinyl derivatives |
IL303688A (en) * | 2020-12-18 | 2023-08-01 | UCB Biopharma SRL | Amorphous solid dispersions |
US20240083925A1 (en) * | 2020-12-18 | 2024-03-14 | UCB Biopharma SRL | Prodrugs of 2-(3,5-Dichloro-1-methyl-indazol-4-yl)-1-[(1S,3R)-3-(hydroxymethyl)-5-(1-hydroxy-1-methyl-ethyl)-1-methyl-3,4-dihydro-1H-isoquinolin-2-yl]ethanone |
BR112023018175A2 (pt) | 2021-03-08 | 2023-10-31 | Lilly Co Eli | Uso de mevidalen e outros moduladores alostéricos d1 positivos no tratamento de alucinações e psicose relacionada à demência |
WO2022192255A1 (en) | 2021-03-09 | 2022-09-15 | Eli Lilly And Company | Use of mevidalen and other d1 positive allosteric modulators for slowing of parkinson's disease progression |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE97893T1 (de) | 1988-02-19 | 1993-12-15 | Smithkline Beecham Farma | 1,2,3,4-tetrahydroisoquinoline, verfharen zu ihrer herstellung und ihre verwendung als kappa- rezeptor agonisten. |
US5246943A (en) * | 1992-05-19 | 1993-09-21 | Warner-Lambert Company | Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties |
US5236934A (en) * | 1992-08-26 | 1993-08-17 | E. I. Du Pont De Nemours And Company | 1,2,3,4-tetrahydroisoquinolines useful in the treatment of CNS disorders |
US5932590A (en) | 1996-12-05 | 1999-08-03 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
HUP0101280A3 (en) | 1998-02-18 | 2003-02-28 | Neurosearch As | Positive ampa receptor modulator compounds and their use |
AU5959201A (en) | 2000-05-11 | 2001-11-20 | Bristol Myers Squibb Co | Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
US7601739B2 (en) | 2003-08-08 | 2009-10-13 | Virgina Commonwealth University | Compounds having antiestrogenic and tissue selective estrogenic properties, and compounds with anti-androgenic properties for treatment of prostate cancer and androgen receptor dependent diseases |
US7541466B2 (en) | 2003-12-23 | 2009-06-02 | Genzyme Corporation | Tetrahydroisoquinoline derivatives for treating protein trafficking diseases |
US20090099158A1 (en) | 2007-03-01 | 2009-04-16 | Grice Cheryl A | Tetrahydroisoquinoline compounds as modulators of the histamine h3 receptor |
US20120252853A1 (en) * | 2011-04-01 | 2012-10-04 | H. Lundbeck A/S | Positive allosteric modulators of nicotinic acetylcholine receptor |
KR20140107550A (ko) | 2011-12-21 | 2014-09-04 | 액테리온 파마슈티칼 리미티드 | 헤테로시클릴 유도체 및 프로스타글란딘 d2 수용체 조절제로서의 그의 용도 |
JO3316B1 (ar) * | 2013-05-30 | 2019-03-13 | Lilly Co Eli | مركبات 3، 4-داي هيدرو أيزو كوينولين -2(1h)-يل |
-
2014
- 2014-05-15 JO JOP/2014/0163A patent/JO3316B1/ar active
- 2014-05-16 TW TW108104751A patent/TWI691489B/zh active
- 2014-05-16 TW TW103117402A patent/TWI691488B/zh active
- 2014-05-27 PE PE2015002534A patent/PE20152032A1/es unknown
- 2014-05-27 EP EP14732756.3A patent/EP3004061B8/en active Active
- 2014-05-27 PL PL14732756T patent/PL3004061T3/pl unknown
- 2014-05-27 US US14/287,239 patent/US8962654B2/en active Active
- 2014-05-27 ES ES14732756.3T patent/ES2647086T3/es active Active
- 2014-05-27 UA UAA201511029A patent/UA118759C2/uk unknown
- 2014-05-27 JP JP2016516713A patent/JP6130590B2/ja active Active
- 2014-05-27 AU AU2014274435A patent/AU2014274435B2/en active Active
- 2014-05-27 SG SG11201509310QA patent/SG11201509310QA/en unknown
- 2014-05-27 BR BR112015029090-6A patent/BR112015029090B1/pt active IP Right Grant
- 2014-05-27 WO PCT/US2014/039494 patent/WO2014193781A1/en active Application Filing
- 2014-05-27 CN CN201480031030.7A patent/CN105228985B/zh active Active
- 2014-05-27 KR KR1020157033616A patent/KR101808933B1/ko active IP Right Grant
- 2014-05-27 AP AP2015008867A patent/AP2015008867A0/xx unknown
- 2014-05-27 PT PT147327563T patent/PT3004061T/pt unknown
- 2014-05-27 MY MYPI2015704341A patent/MY180751A/en unknown
- 2014-05-27 SI SI201430377T patent/SI3004061T1/sl unknown
- 2014-05-27 RS RS20170896A patent/RS56294B1/sr unknown
- 2014-05-27 MX MX2015016495A patent/MX2015016495A/es active IP Right Grant
- 2014-05-27 CA CA2912849A patent/CA2912849C/en active Active
- 2014-05-27 TN TN2015000514A patent/TN2015000514A1/en unknown
- 2014-05-27 DK DK14732756.3T patent/DK3004061T3/en active
- 2014-05-27 LT LTEP14732756.3T patent/LT3004061T/lt unknown
- 2014-05-27 ME MEP-2017-221A patent/ME02838B/me unknown
- 2014-05-27 EA EA201592082A patent/EA029220B1/ru not_active IP Right Cessation
- 2014-05-27 NZ NZ71380914A patent/NZ713809A/en unknown
- 2014-05-27 HU HUE14732756A patent/HUE034607T2/en unknown
-
2015
- 2015-11-06 ZA ZA2015/08213A patent/ZA201508213B/en unknown
- 2015-11-23 CR CR20150622A patent/CR20150622A/es unknown
- 2015-11-24 CL CL2015003444A patent/CL2015003444A1/es unknown
- 2015-11-26 GT GT201500334A patent/GT201500334A/es unknown
- 2015-11-27 DO DO2015000289A patent/DOP2015000289A/es unknown
- 2015-11-27 PH PH12015502658A patent/PH12015502658B1/en unknown
-
2016
- 2016-04-14 HK HK16104287.6A patent/HK1216314A1/zh unknown
- 2016-10-07 AU AU2016238934A patent/AU2016238934B2/en active Active
-
2017
- 2017-04-13 JP JP2017079775A patent/JP6387433B2/ja active Active
- 2017-10-05 CY CY20171101039T patent/CY1119361T1/el unknown
- 2017-11-06 HR HRP20171696TT patent/HRP20171696T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1216314A1 (zh) | -二氫異喹啉- -基化合物 | |
ZA201905393B (en) | Selectively substituted quinoline compounds | |
IL267031B (en) | Selectively converted quinoline compounds | |
GB201303109D0 (en) | Novel pyrimidine compounds | |
IL245704B (en) | ccr6 compounds | |
SI2970339T1 (sl) | 1-hidroksi-benzooksaboroli kot sredstva proti parazitom | |
HK1207317A1 (en) | Substituted 1,6-naphthyridines 16- | |
GB201300632D0 (en) | Discovery | |
TH1501007139A (th) | สารประกอบ 3,4-ไดไฮโดรไอโซควิโนลิน-2(1h)-อิล | |
TH160948B (th) | สารประกอบ 3,4-ไดไฮโดรไอโซควิโนลิน-2(1h)-อิล | |
GB201321302D0 (en) | Improved garment | |
GB201319736D0 (en) | Improved Garment | |
GB201312705D0 (en) | No access? button | |
AU2013902641A0 (en) | Garment | |
AU2013900691A0 (en) | Garment | |
GB201202989D0 (en) | Wizz through 2 ceilings |